Free Trial
NYSE:AVTR

Avantor (AVTR) Stock Price, News & Analysis

$25.54
-0.10 (-0.39%)
(As of 09/6/2024 ET)
Today's Range
$25.06
â–Ľ
$26.20
50-Day Range
$20.58
â–Ľ
$27.65
52-Week Range
$16.63
â–Ľ
$28.00
Volume
5.13 million shs
Average Volume
6.68 million shs
Market Capitalization
$17.35 billion
P/E Ratio
65.49
Dividend Yield
N/A
Price Target
$27.40

Avantor MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
7.3% Upside
$27.40 Price Target
Short Interest
Bearish
5.36% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-2.25
Upright™ Environmental Score
News Sentiment
1.01mentions of Avantor in the last 14 days
Based on 17 Articles This Week
Insider Trading
Selling Shares
$88,336 Sold Last Quarter
Proj. Earnings Growth
21.78%
From $1.01 to $1.23 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.14 out of 5 stars

Medical Sector

146th out of 910 stocks

Analytical Instruments Industry

7th out of 26 stocks

AVTR stock logo

About Avantor Stock (NYSE:AVTR)

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

AVTR Stock Price History

AVTR Stock News Headlines

Kamala’s Dirty Election Move… Revealed
According to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move…
Brokerages Set Avantor, Inc. (NYSE:AVTR) Target Price at $27.21
Analysts Set Avantor, Inc. (NYSE:AVTR) PT at $27.21
Kamala’s Dirty Election Move… Revealed
According to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move…
Avantor Inc (AVG.MU)
Avantor, Inc. (AVG.F)
Guru Fundamental Report for AVTR
Avantor To Divest Clinical Services Business - Quick Facts
See More Headlines
Receive AVTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avantor and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/26/2024
Today
9/07/2024
Next Earnings (Estimated)
10/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
Measuring And Control Equipment
Fax
N/A
Employees
14,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$27.40
High Stock Price Target
$31.00
Low Stock Price Target
$22.00
Potential Upside/Downside
+7.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
16 Analysts

Profitability

Net Income
$321.10 million
Pretax Margin
6.61%

Debt

Sales & Book Value

Annual Sales
$6.83 billion
Cash Flow
$1.66 per share
Book Value
$7.99 per share

Miscellaneous

Free Float
669,077,000
Market Cap
$17.35 billion
Optionable
Optionable
Beta
1.32
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

AVTR Stock Analysis - Frequently Asked Questions

How have AVTR shares performed this year?

Avantor's stock was trading at $22.83 at the start of the year. Since then, AVTR shares have increased by 11.9% and is now trading at $25.54.
View the best growth stocks for 2024 here
.

How were Avantor's earnings last quarter?

Avantor, Inc. (NYSE:AVTR) announced its quarterly earnings results on Friday, July, 26th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.23 by $0.02. The company had revenue of $1.70 billion for the quarter, compared to the consensus estimate of $1.70 billion. Avantor had a trailing twelve-month return on equity of 12.40% and a net margin of 5.28%.

When did Avantor IPO?

Avantor (AVTR) raised $3 billion in an IPO on Friday, May 17th 2019. The company issued 154,000,000 shares at a price of $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies acted as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

Who are Avantor's major shareholders?

Top institutional shareholders of Avantor include Canada Pension Plan Investment Board (3.38%), Barrow Hanley Mewhinney & Strauss LLC (3.28%), 1832 Asset Management L.P. (1.26%) and Artemis Investment Management LLP (1.19%). Insiders that own company stock include Michael Stubblefield, Frederic Vanderhaegen, Gerard Brophy, James Bramwell, Christophe Couturier, Thomas A Szlosek, Steven W Eck and Rajiv Gupta.
View institutional ownership trends
.

How do I buy shares of Avantor?

Shares of AVTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Avantor own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Avantor investors own include Johnson & Johnson (JNJ), NVIDIA (NVDA), Procter & Gamble (PG), RTX (RTX), Alibaba Group (BABA) and CVS Health (CVS).

This page (NYSE:AVTR) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners